REFERENCES

1. Liouville H. Rétrécissementcardiaque sous aortique. Gaz Med Paris.1869; 24:161-163.
2. Hallopeau L. Rétrécissementventriculo-aortique. Gaz Med Paris.1869; 24:683-684.
3. Brock RC. Functional obstruction of the left ventricle. Guys Hosp Rep.1957; 106:221-238. 
4. Schmincke A. UeberlinksseitigemuskuloseConusstenosen. Dtsch Med Wochenschr. 1907; 33:2082.
5. Teare RD. Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958; 20:1-8.
6. Braunwald E, Lambrew C, Rockoff SD, Ross J Jr, Morrow AG. Idiopathic hypertrophic subaortic stenosis, I: description of the disease based upon an analysis of 64 patients. Circulation. 1964; 29(suppl IV): IV-3-IV-119.
7. Goodwin JF. The frontiers of cardiomyopathy. Br Heart J. 1982; 48:1-18.
8. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG. Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy: a review. ProgCardiovasc Dis. 1985; 28:1-83. 
9. Authors/Task Force members, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G et al. ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). European Heart Journal. 2014; 35:2733–2779.
10. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK andAeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. Journal of the American Medical Association. 1999; 281 :650–655.
11. Moon JC, Fisher NG, McKenna WJ and Pennell DJ. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart. 2004; 90:645–649.
12. E. Douglas Wigle, MD; Harry Rakowski, MD; Brian P. Kimball, MD; William G. Williams, MD. Hypertrophic Cardiomyopathy Clinical Spectrum and Treatment. Circulation..1995; 92: 1680-1692
13. Bonow R, Braunwald E, Zipes DP, Libby P. "The Cardiomyopathies".Braunwald's heart disease: a textbook of cardiovascular medicine (7th ed.). Philadelphia: WB Saunders. 2005.
14. Elliott PM, GimenoBlanes JR, Mahon NG, et al. Relation between severity of left-ventricular hypertrophy andprognosis in patients with hypertrophic cardiomyopathy.Lancet 2000; 357:420–4.
15. Thierfelder L, MacRae C, Watkins H, McKenna W, Vosberg HP, Seidman JG, Seidman C. Familial hypertrophic cardiomyopathy is a disease of the sarcomere. Circulation. 1994;90(suppl I):I-519. Abstract.
16. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O’Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995; 332:1058-1064. 
17. MacRae C, Ghaisas N, McGarry K, McKenna W, Seidman JG, Seidman CE. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. Circulation. 1994;90(suppl I):I-25
18. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell.1994; 77:701-712. 
19. Fananapazir L, Epstein ND. Genotype-phenotype correlations in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical β-myosin heavy chain gene mutations. Circulation.1994; 89:22-32. 
20. Roberts R. Molecular genetics: therapy or terror? Circulation. 1994; 89:499-502. Editorial. 
21. Carrier L, Hengstenberg C, Beckmann JS, Guicheny P, Dufour C, Bercovici J, Dausse E, Berebbi-Bertrand I, Wisnewsky C, Pulvenis D, Fetler L, Vignal A, Weissenbach J, Hillaire D, Feingold J, Bourhour JB, Hagege A, Desnos M, Isnard R, Dubourg O, Komajda M, Schwartz K. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nat Genet. 1993; 4:311-314. 
22. Takemura G, Fujiwara H, Mukoyama M, Saito Y, Nakao K, Kawamura A, Ishida M, Kida M, Uegaito T, Tanaka M, Matsumori A, Fujiwara T, Imura H, Kawai C. Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy. Circulation. 1991; 83:181-190. 
23. Derchi G, Bellone P, Chiarella F, Randazzo M, Zino V, Vecchio C. Plasma levels of atrial natriuretic peptide in hypertrophic cardiomyopathy. Am J Cardiol. 1992; 70:1502-1504.
24. Marian AJ, Yu QT, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 1933; 342:1085-1086.
25. Watkins H, Rosenzweig A, Hwang DS, Levi T, McKenna W, Seidman CE, Seidman JG. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med.1992; 326:1108-1114.
26. Maron BJ, Lipson LC, Roberts WG, Epstein SE. ‘Malignant’ hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. Am J Cardiol. 1978; 41:1133-1140. 
27. Wigle ED, Heimbecker RO, Gunton RW. Idiopathic ventricular septal hypertrophy causing muscular subaortic stenosis. Circulation. 1962;26:325-340
28. Pollick C, Morgan CD, Gilbert BW, Rakowski H, Wigle ED. Muscular subaortic stenosis: the temporal relationship between systolic anterior motion of the anterior mitral leaflet and pressure gradient. Circulation. 1982; 66:1087-1093.
29. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol.1981; 48:418-428. 
30. Yock PG, Hatle L, Popp RL. Patterns and timing of Doppler-detected intracavity and aortic flow in hypertrophic cardiomyopathy. J Am Coll Cardiol.1986; 8:1047-1058. 
31. Grigg LE, Wigle ED, Williams WG, Daniel LB, Rakowski H. Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making. J Am CollCardiol. 1992; 20:42-52.